Rossari Biotech Ltd vs Saroja Pharma Industries India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 23, 2026

Key Highlights

The Latest Trading Price of Rossari Biotech Ltd is ₹ 387.35 as of 23 Mar 15:30 . The P/E Ratio of Rossari Biotech Ltd changed from 67.2 on March 2021 to 24.5 on March 2025 . This represents a CAGR of -18.27% over 5 yearsThe P/E Ratio of Saroja Pharma Industries India Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Rossari Biotech Ltd changed from ₹ 5388 crore on March 2021 to ₹ 3344 crore on March 2025 . This represents a CAGR of -9.10% over 5 yearsThe Market Cap of Saroja Pharma Industries India Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Rossari Biotech Ltd for the Dec '25 is ₹ 582.59 crore as compare to the Sep '25 revenue of ₹ 588.18 crore. This represent the decline of -0.95% The revenue of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Rossari Biotech Ltd for the Dec '25 is ₹ 69.78 crore as compare to the Sep '25 ebitda of ₹ 74 crore. This represent the decline of -5.7% The ebitda of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Rossari Biotech Ltd changed from ₹ 34.9 crore to ₹ 32.77 crore over 7 quarters. This represents a CAGR of -3.53% The net profit of Saroja Pharma Industries India Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Rossari Biotech Ltd changed from 3.28 % on March 2021 to 2.41 % on March 2025 . This represents a CAGR of -5.98% over 5 yearsThe Dividend Payout of Saroja Pharma Industries India Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Rossari Biotech Ltd

Rossari Biotech Limited was founded in 2003 as a partnership firm in the name of Rossari Labtech by Mr. Edward Walter Menezes, and Mr. Sunil Srinivasan Chari, who are both career-technocrats cumulatively having over 45 years of experience in the specialty chemicals industry.
It was further renamed to Rossari Biotech Limited and converted into a company in 2009.
The Company has two state-of-the art facilities at Dahej, Gujarat and Silvassa, Dadra Nagar & Haveli and is mainly engaged in manufacturing, selling and distribution of specialty chemicals.
The products cater to global brands in the FMCG sector and find applications in a host of consumer-centric products and home and personal care products, textile chemicals, animal health and nutrition and cosmetic products. During the FY2020, 50,00,000 equity shares of face value of Rs 10 each was sub-divided into 2,50,00,000 Equity Shares of face value of Rs 2 each.

About Saroja Pharma Industries India Ltd

Saroja Pharma Industries India Ltd was originally incorporated as Private Limited, in the name and style of 'Saroja Pharma Industries India Private Limited' on January 14 , 2019 vide Certificate of Incorporation issued by the Registrar of Companies, Mumbai, Maharashtra.
Later on, Company was converted into Public Limited Company and due to conversion, name of the Company changed to 'Saroja Pharma Industries India Limited' through fresh Certificate of Incorporation dated April 18, 2023. Saroja Pharma Industries India Limited was founded in year, 2019 by Mr. Biju Gopinathan Nair and Mr. Manish Dasharath Kamble, upon becoming a globally integrated and highly regarded pharmaceutical and healthcare company, the two Promoters embarked on a journey to establish their business. In its initial stages, the Company operated as a Private Limited entity, operating with the name 'Saroja Pharma Industries India Private Limited.

FAQs for the comparison of Rossari Biotech Ltd and Saroja Pharma Industries India Ltd

Which company has a larger market capitalization, Rossari Biotech Ltd or Saroja Pharma Industries India Ltd?

Market cap of Rossari Biotech Ltd is 2,270 Cr while Market cap of Saroja Pharma Industries India Ltd is 11 Cr

What are the key factors driving the stock performance of Rossari Biotech Ltd and Saroja Pharma Industries India Ltd?

The stock performance of Rossari Biotech Ltd and Saroja Pharma Industries India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Rossari Biotech Ltd and Saroja Pharma Industries India Ltd?

As of March 23, 2026, the Rossari Biotech Ltd stock price is INR ₹410.0. On the other hand, Saroja Pharma Industries India Ltd stock price is INR ₹28.15.

How do dividend payouts of Rossari Biotech Ltd and Saroja Pharma Industries India Ltd compare?

To compare the dividend payouts of Rossari Biotech Ltd and Saroja Pharma Industries India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.